Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: An open trial

Psychoneuroendocrinology

Volumn 23, Issue 1, 1998, Pages 73-88

  Sundström, Inger ^a   Bäckström, Torbjörn ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Neuroactive steroids; Pregnanolone; Premenstrual syndrome (PMS); Saccadic eye velocity; Sedation; Serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM; ELTANOLONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; EYE MOVEMENT; FEMALE; HORMONE SENSITIVITY; HUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SEDATION;

ADULT; AFFECT; CITALOPRAM; DEPRESSION; EYE MOVEMENTS; FEMALE; HUMANS; LIBIDO; MIDDLE AGED; PREGNANOLONE; PREMENSTRUAL SYNDROME; RADIOIMMUNOASSAY; SEROTONIN UPTAKE INHIBITORS;

EID: 0031747143     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(97)00064-4     Document Type: Article

References (56)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. US Department of Health and Human Services, Washington, DC.
2. Andersch, B., Wendestam, C., Hahn, L. and Öhman, R. (1986) Premenstrual complaints. I. Prevalence of premenstrual symptoms in a Swedish urban population. Journal of Psychosomatic Obstetrics and Gynaecology 5, 39-49.
3. Bahill, A. T., Clark, M. R. and Stark, L. (1975) The main sequence, a tool for studying human eye movements. Mathematical Biosciences 24, 191-204.
4. Ball, D. M., Glue, P., Wilson, S. and Nutt, D. J. (1991) Pharmacology of saccadic eye movements in man: 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology 105, 361-367.
5. Baloh, R. W., Sills, A. W., Kurnley, W. E. and Honrubia, V. (1975) Quantitative measurement of saccade amplitude, duration, and velocity. Neurology 25, 1065-1070.
6. Becker, W. (1989) Metrics. In The Neurobiology of Saccadic Eye Movements, ed. R. H. Wurtz and M. E. Goldberg, pp. 13-67. Elsevier, Amsterdam.
7. Biegon, A. (1990) Effects of steroid hormones on the serotonergic system. Annals of the New York Academy of Science 600, 427-434.
8. A-receptor function. Pharmacology, Biochemistry and Behavior 45, 423-428.
9. Bäckström, T., Andersson, A., Baird, D. T. and Selstam, G. (1986) The human corpus luteum secretes 5α-pregnan-3,20-dione. Acta Endocrinologica (Copenhagen) 111, 116-121.
10. Bäckström, T., Sanders, D., Leask, R., Davidson, D., Warner, P. and Bancroft, J. (1983) Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic Medicine 45, 503-507.
11. Carl, P., Högskilde, S., Lang-Jensen, T., Bach, V., Jacobsen, J., Sörensen, M. B., Grälls, M. and Widlund, L. (1994) Pharmacokinetics and pharmacodynamics of eltanolone (pregnaolone), a new steroid intravenous anaesthetic, in humans. Acta Anaesthesiologica Scandinavica 38, 734-741.
12. Coprechot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J. N., Touyer, G., Mouren, M., Prasad, V. V. K., Banner, C., Sjövall, J., Baulieu, E. E. and Robel, P. (1993) Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133, 1003-1008.
13. Coupland, N., Glue, P. and Nutt, D. J. (1992) Challenge tests: Assessment of the noradrenergic and GABA systems in depression and anxiety disorders. Molecular Aspects of Medicine 13, 221-247.
14. Dennerstein, L., Gotts, G., Brown, J. B., Morse, C. A., Farley, T. M. and Pinol, A. (1994) The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers. Psychoneuroendocrinology 19, 293-304.
15. Eriksson, E., Hedberg, M. A., Andersch, B. and Sundblad, C. (1995) The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12, 167-176.
16. Eriksson, E. and Humble, M. (1990) Serotonin in psychiatric pathophysiology. In The Biological Basis of Psychiatric Treatment: Progress in Basic Clinical Pharmacology, ed. R. Pohl and S. Gershon, pp. 66-119. Karger, Basel.
17. Gentles, W. and Thomas, E.L. (1971) Effect of benzodiazepines upon saccadic eye movements in man. Clinical Pharmacology and Therapeutics 2, 563-576.
18. Glue, P. (1991) The pharmacology of saccadic eye movements. Journal of Psychopharmacology 5, 377-387.
19. Glue, P., Bailey, J., Wilson, S., Hudson, A. and Nutt, D. J. (1992) Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sciences 50, 25-30.
20. Graze, K. K., Nee, J. and Endicott, J. (1990) Premenstrual depression predicts future major depressive disorder. Acta Psychiatrica Scandinavica 81, 201-205.
21. Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P. and Wang, K. (1995) Estrogen augments serotonergic activity in postmenopausal women. Biological Psychiatry 37, 434-441.
22. Hammarbäck, S., Ekholm, U. B. and Bäckström, T. (1991) Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinologica (Copenhagen) 125, 132-137.
23. Hammarbäck, S. and Bäckström, T. (1988) Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstetrica et Gynecologica Scandinavica 67, 159-166.
24. Hammarbäck, S., Bäckström, T., Holst, J., von Schoultz, B. and Lyrenäs, S. (1985) Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement treatment. Acta Obstetrica et Gynecologica Scandinavica 64, 393-397.
25. Hammarbäck, S., Bäckström, T. and MacGibbon-Taylor, B. (1989a) Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. Journal of Psychosomatic Obstetrics and Gynaecology 10, 25-42.
26. Hammarbäck, S., Damber, J.-E. and Bäckström, T. (1989b) Relationship between symptom severity and hormone changes in women with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 68, 125-130.
27. Hikosaka, O. and Wurtz, R.H. (1985) Modification of saccadic eye movements by GABA-related substances: I. Effect of muscimol and bicuculline in the monkey superior colliculus. Journal of Neurophysiology 53, 266-291.
28. Hommer, D. W., Matsuo, V., Wolkowitz, O., Chrousos, G., Greenblatt, D. J., Weingarter, H. and Paul, S. M. (1986) Benzodiazepine sensitivity in normal human subjects. Archives of General Psychiatry 43, 542-551.
29. Jäntti, V., Lang, A.H., Keskinen, E., Lehtinen, I. and Pakkanen, A. (1983) Acute effects of intravenously given alcohol on saccadic eye movements and subjective evaluations of intoxication. Psychopharmacology 79, 251-255.
30. Kaspi, S. P., Otto, M. W., Pollack, M. H., Eppinger, S. and Rosenbaum, J. F. (1994) Premenstrual exacerbation of symptoms in women with panic disorder. Journal of Anxiety Disorders 8, 131-138.
31. Ladisich, W. (1977) Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinology 2, 257-266.
32. Landgren, S., Aasly, J., Bäckström, T., Dubrovsky, B. and Danielsson, E. (1987) The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiologica Scandinavica 131, 33-42.
33. A-receptor function: molecular and physiological determinants. In GABAergic Synaptic Transmission, ed. G. Biggio and E. Costa, pp. 269-279. Raven Press, New York.
34. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L. and Paul, S. M. (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232, 1004-1007.
35. Marshall, R. W., Griffiths, A. N. and Richens, A. (1985) A microcomputer system to assess CNS depression from the analysis of the dynamics of saccadic eye movements. British Journal of Clinical Pharmacology 20, 304-305.
36. Marshall, R. W. and Richens, A. (1989) An IBM-based system for the generation, collection and analysis of saccadic and smooth pursuit eye movements. British Journal of Clinical Pharmacology 28, 752-753.
37. McCormack, H. M., Horne, D. J. L. and Sheather, S. (1988) Clinical application of visual analogue scales: a critical review. Psychological Medicine 18, 1007-1019.
38. Mercer, A. J., Marshall, R. W. and Richens, A. (1990) Saccadic eye movements as a method of psychometric assessment. In Ambulatory Anaesthesia and Sedation, ed. I. D. Klepper, L. D. Saunders and M. Rosen, pp. 88-105. Blackwell, Oxford.
39. Mortola, J. F. (1994) A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Safety 10, 160-169.
40. Norberg, L., Wahlström, G. and Bäckström, T. (1987) The anaesthetic potency of 3α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one determined with an intravenous EEG-threshold method in male rats. Pharmacology and Toxicology 61, 42-47.
41. Nutt, D. J., Glue, P., Lawson, C. and Wilson, S. (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodhizepine receptor sensitivity in panic disorder. Archives of General Psychiatry 47, 917-925.
42. Pearlstein, T. B. and Stone, A. B. (1994) Long-term fluoxetine treatment of late luteal phase dysphoric disorder. Journal of Clinical Psychiatry 55, 332-335.
43. Pearlstein, T. P., Frank, E., Rivera-Tovar, A., Thoft, J. S., Jacobs, E. and Mieczkowski, T. A. (1990) Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. Journal of Affective Disorders 20, 129-134.
44. Purdy, R. H., Morrow, A. L., Moore, P. H. and Paul, S. M. (1991) Stress-induced elevations of the γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proceedings of the National Academy of Sciences of the USA 88, 4553-4557.
45. Romeo, E., Brancati, A., de Lorenzo, A., Fucci, P., Furnari, C., Pompili, E., Sasso, G. F., Troisi, A. and Pasini, A. (1996) Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clinical Neuropharmacology 19, 366-369.
46. Roy-Burne, P. P., Cowley, D. S., Greenblatt, D. J., Shader, R. I. and Hommer, D. (1990) Reduced benzodiazepine sensitivity in panic disorder. Archives of General Psychiatry 47, 534-538.
47. Schmidt, P. J., Purdy, R. H., Moore, P. H., Paul, S. M. and Rubinow, D. R. (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. Journal of Clinical Endocrinology and Metabolism 79, 1256-1260.
48. Shekhar, A. (1994) Effects of treatment with imipramine and clonazepam on an animal model of panic disorder. Biological Psychiatry 36, 748-758.
49. Shekhar, A., Keim, S. R., Simon, J. R. and McBride, W. J. (1996) Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacology, Biochemistry and Behavior 55, 249-256.
50. Steiner, M., Steinberg, S., Stewart, S., Carter, D., Berger, C., Reid, R., Grover, D. and Streiner, D. (1995) Fluoxetine in the treatment of premenstrual dysphoria. New England Journal of Medicine 332, 1529-1534.
51. Sundblad, C., Hedberg, M. A. and Eriksson, E. (1993) Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsychopharmacology 9, 133-145.
52. Sundström, I., Ashbrook, D. and Bäckström, T. (1997) Reduced benzodiazepine sensitivity in patients with premenstrual syndrome, a pilot study. Psychoneuroendocrinology 22, 25-38.
53. Sundström, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., Bäckström, T. (in press) Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology, in press.
54. Uzunov, D. P., Cooper, T. B., Costa, E. and Guidotti, A. (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proceedings of the National Academy of Sciences of the USA 93, 12599-12604.
55. Wang, M. D., Seippel, L., Purdy, R. H. and Bäckström, T. (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnan-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. Journal of Clinical Endocrinology and Metabolism 81, 1076-1082.
56. Wieland, S., Lan, N. C., Mirasedeghi, S. and Gee, K. W. (1991) Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Research 565, 263-268.